Dr. Deborah Dudgeon is a medical oncologist who has focused her clinical practice predominantly in palliative care. In addition to her work at the Canadian Partnership Against Cancer, she is the Head of Palliative Medicine at Queen’s University and Kingston General Hospital. Dr. Dudgeon was the first Head of the Palliative Care Program at Cancer Care Ontario (from 2004 to 2010), where she was instrumental in implementing the Provincial Palliative Care Integration Project.
Dr. Dudgeon is the Chair of the Palliative Medicine Subspecialty Committee for the Royal College of Physicians and Surgeons of Canada. She is also a past President of the Canadian Society of Palliative Care Physicians. She has served as the co-chair of the Advisory Committee on Palliative Medicine for the Conjoint Training Program at the Royal College of Physicians and Surgeons of Canada, and the College of Family Physicians of Canada. She has also served as the co-chair of the Symptom Control committee at the National Cancer Institute of Canada Clinical Trials Group, and as a member of the Advisory Committee on Research for the National Cancer Institute of Canada.
Dr. Dudgeon received her MD from McMaster University.
Dr. Dudgeon is known internationally for her research into dyspnea (shortness of breath) and was a mentor in the International Palliative Care Leadership Development Program funded by the Open Society Foundation, Center for Global Health National Cancer Institute, and Princess of Wales Memorial fund.
Areas of Expertise (3)
Award of Excellence (professional)
Ontario Medical Association Palliative Care Section
Eduardo Bruera Award in Palliative Medicine (professional)
Canadian Society of Palliative Care Physicians
Innovations in Health Care Awards (professional)
Ministry of Health and Long-Term Care
Premier’s Award, Health Sciences (professional)
Nominated by George Brown College
Dorothy Ley Award of Excellence in Palliative Care (professional)
Ontario Palliative Care Association
McMaster University Medical School: MD, Medical School 1985
- Working group for the development of a subspecialty in Palliative Medicine in Canada: Co-chair
- Journal of Pain and Symptom Management: Editorial Board Member
Media Appearances (1)
'Vulnerable Elders Survey' Predicts Breast Ca Outcomes
MedPage Today online
The Vulnerable Elders Survey (VES-13) is an easily used tool that was able to predict functional decline and death within 12 months of breast cancer treatment among older women with newly diagnosed, nonmetastatic, early-stage breast cancer, according to a study online in Cancer.
Women who have been successfully treated for breast cancer have been shown to have significantly greater dyspnea and activity restriction than healthy individuals but contributory mechanisms are unknown.
We therefore compared dyspnea assessments, respiratory and peripheral muscle strength, pulmonary function tests and cardiopulmonary responses to incremental treadmill exercise in 29 women treated for breast cancer and 29 age-matched healthy controls.
The purpose of this study was to measure opioid prescription (OP) rates in elderly cancer outpatients around the time of assessment for pain and to evaluate factors associated with receiving OPs for those with severe pain.
Ontario's cancer system is unique because it has implemented two standardized assessment tools population-wide to improve care: the Edmonton Symptom Assessment System (ESAS) measures severity of nine symptoms (scale 0 to 10; 10 indicates the worst) and the Palliative Performance Scale (PPS) measures performance status (scale 0 to 100; 0 indicates death). This article describes the trajectory of ESAS and PPS scores 6 months before death.
For ambulatory cancer patients, Ontario has standardized symptom and performance status assessment population-wide, using the Edmonton Symptom Assessment System (ESAS) and Palliative Performance Scale (PPS). In a broad cross-section of cancer outpatients, the authors describe the ESAS and PPS scores and their relation to patient characteristics.